Rethinking Clinical Trials

AUGUST 30, 2023

There are 4 components to the treat-to-target approach: record disease activity using a composite measure every 3 months; specify disease activity target; adjust medications to target; and document shared decision making. However, there is a gap between collecting the PROs and communicating about the PROs with patients.

Trials 141

Trials Clinical Research Coordinator Medicine Clinical Trials 141

XTalks

AUGUST 31, 2022

Ayesha shared news about another significant FDA approval for a gene therapy to treat transfusion-dependent beta thalassemia. Hear more about the therapy, some of the setbacks bluebird has had to face on the road to its approval and why the treatment has a steep price tag. Bluebird’s $2.8M

Gene Therapy 52

Gene Therapy FDA Approval Life Science Gene 52

Rethinking Clinical Trials

MAY 10, 2023

Participants shared that genetic information is a type of information they want to get back. cover the lifespan, and have shared all baseline elements. More than 631,000 participants have enrolled in All of Us with continued growth. More than 80% of All of Us participants are underrepresented in biomedical research.

Medicine 130

Medicine Research Clinical Trials Clinical Trials 130

Rethinking Clinical Trials

MARCH 6, 2024

The dietician met with the patient to share education about nutrition, portion size, recipes to make food taste good, and information via an optional diabetes self-management program. Clinic staff included a dietitian, a nurse and a community health worker. They also screened for complications and close care gaps.

Clinical Trials 141

Clinical Trials Clinical Trials Medicine Trials 141

The Pharma Data

NOVEMBER 29, 2021

1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). Researchers in South Africa and around the world are conducting studies to better understand many aspects of Omicron and will continue to share the findings of these studies as they become available.

Vaccination 52

Vaccination Vaccine Genome Genomics 52

pharmaphorum

DECEMBER 17, 2020

The social media platform, which allows users to share short and often frivolous video clips, has a growing number of experts using it to communicate important information to a broad audience, and particular teenagers and young adults.

Scientist 97

Scientist Vaccination Vaccine Medicine 97

Rethinking Clinical Trials

JULY 6, 2023

The DCT space is evolving and will require more commentary on guidance, sharing research, and effective implementation. Discussion Themes -As an early adopter of DCTs, could you share your experience and perspective on these issues? Learn more Read more about Decentralized Clinical Trials.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

World of DTC Marketing

SEPTEMBER 7, 2022

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. To achieve this vision, the matrix organization, which slows innovation and changes market conditions, will be replaced by employees who understand and share the company’s vision.

Pharma Companies 210

Pharma Companies Marketing Drugs Production 210

Cloudbyz

JUNE 2, 2020

As a Salesforce admin, you can share this trick with your entire user base. Create a folder called ‘Dynamic Reports’ Share the folder to users who should access these reports. Salesforce uses these UI tags: fv0 , fv1 , fv2 for custom filters added after standard filters in URLs to run the report. Let’s decode the magic!

Production 54

Production 54

Rethinking Clinical Trials

JULY 27, 2022

Results have been shared for the Ivermectin-400 and Fluticasone arms. The measured outcomes for ACTIV-6 are days of benefit and time to recovery/hospitalization and death. ACTIV-6 is actively recruiting across 93 sites with 5,034 randomized. The study has closed the Fluvoxamine-50 and Ivermectin-600 arms. Learn more about ACTIV-6.

Trials 169

Trials Pharmacy Medicine Clinical Trials 169

Rethinking Clinical Trials

OCTOBER 2, 2023

The PROTEUS-Practice Learning Health Network includes 10 funded projects who come together with members across the PROTEUS Consortium for monthly meetings hosted by PROTEUS that provide a forum to share experiences and lessons learned. With current funding, PROTEUS can address recommendations specifically regarding education materials.

Clinical Trials 152

Clinical Trials Clinical Trials Research Trials 152

Rethinking Clinical Trials

OCTOBER 27, 2022

The manuscript was shared with a news organization called The Markup, and they looked at the Meta Pixel installed by various hospital systems and found 30 out of the top 100 hospitals were using custom fields to share information with Facebook, which constitutes a data breech. pctGR, @Collaboratory1.

Clinical Research 130

Clinical Research Research Clinical Trials Clinical Trials 130

XTalks

MAY 2, 2024

Networking sessions throughout both days allowed participants to discuss industry trends and share experiences, further enriching the collaborative atmosphere of the summit. Sam Davidson, Director of Food Safety at The Acheson Group (TAG) , also emphasized the need for fundamental training for frontline workers in the food industry.

Compliance 108

Compliance Regulation Production Containment 108

Pharmaceutical Technology

APRIL 13, 2023

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. Sickle cell disease is an inherited blood disorder that is caused by mutations in the HBB gene, which codes for the oxygen-carrying protein haemoglobin in red blood cells.

Gene Therapy 147

Gene Therapy Gene FDA Approval Licensing 147

XTalks

FEBRUARY 8, 2024

Along with the hefty price tag for screen time that may not be perceived to be a worthwhile investment, and despite favoring advertising at other major events like the Grammys, pharma tends to stay somewhat clear of all the Super Bowl hoopla. Bayer is preparing to file for FDA approval based on strong Phase III data it shared last month.

Life Science 105

Life Science Marketing Branding Drugs 105

Rethinking Clinical Trials

MAY 19, 2023

The team wanted the visualization designed for shared decision making, with an emphasis on patient information needs and comprehension and physician information needs and workflow. The team’s goals were to design for the primary care setting because 85% of hypertension care is in this setting.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

Pharmaceutical Technology

FEBRUARY 22, 2023

Both drugs come with a high price tag. In its past statements shared with other outlets, Amgen stated that patents need to give researchers wide protection to incentivise new inventions. Both drugs are monoclonal antibodies that inhibit the protein PCSK9. Amgen sued the two companies in 2014 over supposed patent infringement.

Antibody 262

Antibody Drugs Protein Sales 262

pharmaphorum

JANUARY 24, 2022

IBM said the sell-off is tagged as “a clear next step” as it focuses on its platform-based hybrid cloud and artificial intelligence strategy, but it’s no secret that Watson Health has failed to live up to its early promise. .”

Radiology 111

Radiology Marketing Genome Genomics 111

pharmaphorum

AUGUST 17, 2020

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

Regulation 97

Regulation Marketing Sales Branding 97

Rethinking Clinical Trials

NOVEMBER 21, 2022

The FIRST-ABC trial adopted a pragmatic design with a heterogenous patient cohort where the indication to start NRS was based on physiological criteria, which allowed the results to be applicable to all situations where HFNC is started. Many other trials in the country were behind and everyone else had to stop. pctGR, @Collaboratory1.

Trials 130

Trials Clinical Trials Clinical Trials Packaging 130

Rethinking Clinical Trials

NOVEMBER 21, 2023

There was also an option to complete a survey to share reasons for opting out. Nudge used an opt out approach, with IRB approval because it was a low-risk intervention and having patients consent on a large scale would be challenging and might bias the sample to more adherent patients. The study would then recalculate the gaps.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Development 141

pharmaphorum

OCTOBER 21, 2021

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug. Pushback from doctors in particular is causing anxiety for investors, as that may not be affected much if CMS opts to approve reimbursement, and shares in the company fell a little over 6% following the results announcement.

Sales 122

Sales Doctors Doctor Gene Therapy 122

pharmaphorum

JUNE 12, 2022

Trading in bluebird’s shares was suspended during the two-day meeting, and the positive outcome suggests the stock may rise when it resumes on Monday, and firm up confidence in other gene therapy stocks after a tumultuous couple of years in which safety has been thrust into the spotlight.

Gene Therapy 59

Gene Therapy Gene Marketing Trials 59

pharmaphorum

AUGUST 21, 2022

Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. Auvelity is the first drug Axsome has taken through to regulatory approval, but could be the first of a string of new products for the company, according to Tabuteau.

Drugs 98

Drugs FDA Approval Production Marketing 98

The Pharma Data

OCTOBER 29, 2021

a cash tender offer to buy all outstanding shares of common stock of Acceleron, for$ 180 in cash, without interest and lower any required duty withholding. of Acceleron’s outstanding shares. As preliminarily blazoned on October 12, 2021, Merck commenced, through a attachment, Astros Merger Sub,Inc.,

Containment 52

Containment Regulation Vaccination Vaccine 52

XTalks

OCTOBER 19, 2023

In August, Campbell Soup acquired Rao’s sauce owner Sovos Brands for $23 per share, reflecting a total value of a staggering $2.7 Despite the premium price tag, the brand has gained a cult following thanks to its inclusion of high quality ingredients and successful word-of-mouth marketing.

Branding 59

Branding Packaging Packaging Production 59

Rethinking Clinical Trials

JANUARY 19, 2023

Hopefully you can share what has been learned. Tags #pctGR, @Collaboratory1 The post Grand Rounds Ethics and Regulatory Series January 13, 2023: Ethical Considerations When Vulnerable Populations are Subjects in Pragmatic Trials (Emily A. You need to have a plan in place for assessing capacity and ability to consent. .

Trials 130

Trials Clinical Trials Clinical Trials Research 130

XTalks

NOVEMBER 10, 2020

Inherent risks can be minimized by: Allowing information to be shared with various stakeholders across global supply chains. Implementing these technologies would require investing in handheld computers and tablets, barcode label printers and scanners, and special labels and tags.

Production 105

Production Sales Manufacturing Regulation 105

pharmaphorum

MARCH 23, 2022

Vyvgart (efgartigimod alfa) became the first drug in the FcRn class to be approved by the FDA last December, and despite a $225,000 annual price tag is predicted to make relatively modest sales in its IV version, which will compete with other IV gMG drugs like AstraZeneca/Alexion’s C5 inhibitor Soliris (eculizumab).

Antibody 52

Antibody Sales FDA Approval Trials 52

XTalks

DECEMBER 13, 2023

The revolutionary CRISPR/Cas9 technology was discovered by Jennifer Doudna and CRISPR Therapeutics co-founder Emmanuelle Charpentier who both shared the 2020 Nobel Prize for it. Casgevy is also the first ever CRISPR/Cas9-based therapy approved in the US. Vertex-CRISPR’s Casgevy has a US list price of $2.2

Gene Therapy 98

Gene Therapy FDA Approval Gene In-Vivo 98

XTalks

FEBRUARY 11, 2022

On February 3, NBCUniversal announced that it was officially sold out of commercial time, with 30-second ad slots commanding a price tag of as much as $7 million in some cases. . In the commercial, tuxedo-clad actors Seth Rogen and Paul Rudd are sitting on the steps of a church and sharing a bag of Lay’s chips before Rogen’s wedding.

Containment 97

Containment Production Branding Marketing 97

pharmaphorum

JANUARY 11, 2021

Late last year, bluebird’s shares tanked after the FDA laid out additional manufacturing standards for its lead gene therapy product, Lentiglobin, in sickle cell anaemia that could hold up filing until late 2022. million price tag.

Gene Therapy 66

Gene Therapy Gene Genetic Disease Manufacturing 66

Pharmaceutical Technology

MARCH 22, 2023

The pharmaceutical industry began using radio frequency identification (RFID) tags in the early 2000s. Pfizer was the first to use the tech, adding RFID tags to track a Viagra (sildenafil) shipment circa 2006. Twenty years ago, the cost of implementing RFID tags and the ecosystem (software) was much more expensive than today.

Production 264

Production Pharma Production Pharma Companies Drugs 264

XTalks

FEBRUARY 14, 2022

From heart-shaped treats to to buy one, get one free (BOGO) deals to share with loved ones, restaurants nationwide are celebrating the holiday in a delicious way. The kits include skewers, festive wax paper, a burlap wrap and an original Maine Lobster Valentine tag. White Castle.

Packaging 98

Packaging Packaging Branding Marketing 98

Drug Discovery World

JANUARY 30, 2024

Other Challenges: Limited insurance coverage: Many insurance companies are hesitant to cover CGTs due to their high price tags and limited long-term data. As industry leaders, we have a shared purpose to collaborate and find solutions for today’s demands; this conference provides the platform to do just that.

Gene Therapy 70

Gene Therapy Manufacturing Gene Clinical Trials 70

pharmaphorum

JANUARY 21, 2022

This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Finding solutions.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

NOVEMBER 27, 2022

The sooner insights can be shared about a potential problem, the better different parts of the chain can react and alter their processes accordingly. Automated systems allow suppliers to maintain complete traceability over their processes and communicate in the most effective way possible.

Production 105

Production Manufacturing Drugs Marketing 105